Several months ago, six thousand hemophiliacs agreed to settle a class-action lawsuit against the makers of a blood-clotting factor that was contaminated with the AIDS virus more than a decade ago. Under terms of the settlement, hemophiliacs or their survivors would receive 100 thousand dollars each. But as Neil Tickner of member station WHYY reports, the deal has been delayed by the government and private insurers claiming that part of the settlement should be used to pay off benefits provided to hemophiliacs over the years.
Copyright 1997 NPR
